Deleted in malignant brain tumors-1 protein (DMBT1): A pattern recognition receptor with multiple binding sites

International Journal of Molecular Sciences

Volumn 11, Issue 12, 2010, Pages 5212-5233

  Ligtenberg, Antoon J M ^a   Karlsson, Niclas G ^b   Veerman, Enno C I ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Dental caries; Innate immunity; Mucosal protection; SRCR domains

Indexed keywords

DELETED IN MALIGNANT BRAIN TUMORS 1 PROTEIN; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN A; LACTOFERRIN; PATTERN RECOGNITION RECEPTOR; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; DMBT1 PROTEIN, HUMAN; PROTEIN BINDING;

BACTERIUM ADHERENCE; BINDING SITE; CONFORMATIONAL TRANSITION; HELICOBACTER PYLORI; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA VIRUS A; INNATE IMMUNITY; LIGAND BINDING; MUCOSAL IMMUNITY; NONHUMAN; PROTEIN DOMAIN; PROTEIN GLYCOSYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; STREPTOCOCCUS GORDONII; STREPTOCOCCUS MUTANS; ZONA PELLUCIDA; ANIMAL; CHEMISTRY; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; PROTEIN MOTIF; PROTEIN TERTIARY STRUCTURE; STREPTOCOCCUS;

HELICOBACTER PYLORI; INFLUENZA A VIRUS; METAZOA;

AMINO ACID MOTIFS; ANIMALS; HELICOBACTER PYLORI; HIV-1; HUMANS; IMMUNITY, MUCOSAL; INFLUENZA A VIRUS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CELL SURFACE; STREPTOCOCCUS;

EID: 78650997074     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms1112521     Document Type: Review

References (120)

1. Tlaskalova-Hogenova, H.; Tuckova, L.; Mestecky, J.; Kolinska, J.; Rossmann, P.; Stepankova, R.; Kozakova, H.; Hudcovic, T.; Hrncir, T.; Frolova, L.; Kverka, M. Interaction of mucosal microbiota with the innate immune system. Scand. J. Immunol. 2005, 62, 106-113.
2. Schenkels, L.C.P.M.; Veerman, E.C.I.; Nieuw Amerongen, A.V. Biochemical composition of human saliva in relation to other mucosal fluids. Crit. Rev. Oral Biol. Med. 1995, 6, 161-175.
3. Valdez, I.H.; Fox, P.C. Diagnosis and management of salivary dysfunction. Critical Reviews in Oral Biol. Med. 1993, 4, 271-277.
4. Daniels, T.E. Evaluation, differential diagnosis, and treatment of xerostomia. J. Rheumatol. 2000, 27, 6-10.
5. Almstahl, A.; Wikstrom, M.; Stenberg, I.; Jakobsson, A.; Fagerberg-Mohlin, B. Oral microbiota associated with hyposalivation of different origins. Oral Microbiol. Immunol. 2003, 18, 1-8.
6. Scannapieco, F.A. Role of oral bacteria in respiratory infection. J. Periodontol. 1999, 70, 793-802.
7. Kolenbrander, P.E.; London, J. Adhere today, here tomorrow: Oral bacterial adherence. J. Bacteriol. 1993, 175, 3247-3252.
8. Gibbons, R.J. Adherent interactions which may affect microbial ecology in the mouth. J. Dent. Res. 1984, 63, 378-385.
9. Emilson, C.G.; Ciardi, J.E.; Olsson, J.; Bowen, W.H. The influence of saliva on infection of the human mouth by mutans streptococci. Arch. Oral Biol. 1989, 34, 335-340.
10. Rudney, J.D.; Pan, Y.; Chen, R. Streptococcal diversity in oral biofilms with respect to salivary function. Arch. Oral Biol. 2003, 48, 475-493.
11. Rudney, J.D. Does variability in salivary protein concentrations influence oral microbial ecology and oral health? Crit. Rev. Oral Biol. Med. 1995, 6, 343-367.
12. Ericson, T.; Rundegren, J. Characterization of a salivary agglutinin reacting with a serotype c strain of Streptococcus mutans. Eur. J. Biochem. 1983, 133, 255-261.
13. Ligtenberg, A.J.; Veerman, E.C.; Nieuw Amerongen, A.V. A role for Lewis a antigens on salivary agglutinin in binding to Streptococcus mutans. Antonie van Leeuwenhoek 2000, 77, 21-30.
14. Rundegren, J. Calcium-dependent salivary agglutinin with reactivity to various oral bacterial species. Infect. Immun. 1986, 53, 173-178.
15. Rundegren, J.; Arnold, R.R. Differentiation and interaction of secretory immunoglobulin A and a calcium-dependent parotid agglutinin for several bacterial strains. Infect. Immun. 1987, 55, 288-292.
16. Boackle, R.J.; Connor, M.H.; Vesely, J. High molecular weight non-immunoglobulin salivary agglutinins (NIA) bind C1Q globular heads and have the potential to activate the first complement component. Mol. Immunol. 1993, 30, 309-319.
17. Mitoma, M.; Oho, T.; Shimazaki, Y.; Koga, T. Inhibitory effect of bovine milk lactoferrin on the interaction between a streptococcal surface protein antigen and human salivary agglutinin. J. Biol. Chem. 2001, 276, 18060-18065.
18. Ligtenberg, A.J.M.; Bikker, F.J.; de Blieck-Hogervorst, J.M.A.; Veerman, E.C.I.; Nieuw Amerongen, A.V. Binding of salivary agglutinin to IgA. Biochem. J. 2004, 383, 159-164.
19. End, C.; Lyer, S.; Renner, M.; Stahl, C.; Ditzer, J.; Holloschi, A.; Kuhn, H.M.; Flammann, H.T.; Poustka, A.; Hafner, M.; Mollenhauer, J.; Kioschis, P. Generation of a vector system facilitating cloning of DMBT1 variants and recombinant expression of functional full-length DMBT1. Protein Expres. Purif. 2005, 41, 275-286.
20. Holmskov, U.; Lawson, P.; Teisner, B.; Tornoe, I.; Willis, A.C.; Morgan, C.; Koch, C.; Reid, K.B.M. Isolation and characterization of a new member of the Scavenger receptor superfamily, glycoprotein-340 (GP340), as a lung surfactant protein D binding molecule. J. Biol. Chem. 1997, 272, 13743-13749.
21. Ligtenberg, T.J.M.; Bikker, F.J.; Groenink, J.; Tornoe, I.; Leth-Larsen, R.; Veerman, E.C.I.; Amerongen, A.V.N.; Holmskov, U. Human salivary agglutinin binds to lung surfactant proteinD and is identical with scavenger receptor protein gp-340. Biochem. J. 2001, 359, 243-248.
22. Prakobphol, A.; Xu, F.; Hoang, V.M.; Larsson, T.; Bergstrom, J.; Johansson, I.; Frangsmyr, L.; Holmskov, U.; Leffler, H.; Nilsson, C.; Boren, T.; Wright, J.R.; Stromberg, N.; Fisher, S.J. Salivary agglutinin, which binds Streptococcus mutans and Helicobacter pylori, is the lung scavenger receptor cysteine-rich protein gp-340. J. Biol. Chem. 2000, 275, 39860-39866.
23. Holmskov, U.; Mollenhauer, J.; Madsen, J.; Vitved, L.; Gronlund, J.; Tornoe, I.; Kliem, A.; Reid, K.B.M.; Poustka, A.; Skjodt, K. Cloning of GP-340, a putative opsonin receptor for lung surfactant protein D. Proc. Natl. Acad. Sci. USA 1999, 96, 10794-10799.
24. Mollenhauer, J.; Wiemann, S.; Scheurlen, W.; Korn, B.; Hayashi, Y.; Wilgenbus, K.K.; vonDeimling, A.; Poustka, A. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nat. Genet. 1997, 17, 32-39.
25. Tino, M.J.; Wright, J.R. Glycoprotein-340 binds surfactant protein-A (SP-A) and stimulates alveolar macrophage migration in an SP-A-independent manner. Am. J. Respirat. Cell Mol. Biol. 1999, 20, 759-768.
26. Crouch, E.; Hartshorn, K.; Ofek, I. Collectins and pulmonary innate immunity. Immunol. Rev. 2000, 173, 52-65.
27. Mori, M.; Shiraishi, T.; Tanaka, S.; Yamagata, M.; Mafune, K.; Tanaka, Y.; Ueo, H.; Barnard, G.F.; Sugimachi, K. Lack of DMBT1 expression in oesophageal, gastric and colon cancers. Br. J. Cancer 1999, 79, 211-213.
28. Somerville, R.P.T.; Shoshan, Y.; Eng, C.; Barnett, G.; Miller, D.; Cowell, J.K. Molecular analysis of two putative tumour suppressor genes, PTEN and DMBT, which have been implicated in glioblastoma multiforme disease progression. Oncogene 1998, 17, 1755-1757.
29. Wu, W.G.; Kemp, B.L.; Proctor, M.L.; Gazdar, A.F.; Minna, J.D.; Hong, W.K.; Mao, L. Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer. Cancer Res. 1999, 59, 1846-1851.
30. Mollenhauer, J.; Holmskov, U.; Wiemann, S.; Krebs, I.; Herbertz, S.; Madsen, J.; Kioschis, P.; Coy, J.F.; Poustka, A. The genomic structure of the DMBT1 gene: Evidence for a region with susceptibility to genomic instability. Oncogene 1999, 18, 6233-6240.
31. Braidotti, P.; Nuciforo, P.G.; Mollenhauer, J.; Poustka, A.; Pellegrini, C.; Moro, A.; Bulfamante, G.; Coggi, G.; Bosari, S.; Pietra, G.G. DMBT1 expression is down-regulated in breast cancer. Bmc Cancer 2004, 4.
32. Mollenhauer, J.; Muller, H.; Kollender, G.; Lyer, S.; Diedrichs, L.; Helmke, B.; Holmskov, U.; Ligtenberg, T.; Herbertz, S.; Krebs, I.; Madsen, J.; Bikker, F.; Schmitt, L.; Wiemann, S.; Scheurlen, W.; Otto, H.F.; von Deimling, A.; Poustka, A. The SRCR/SID region of DMBT1 defines a complex multi-allele system representing the major basis for its variability in cancer. Genes Chromosomes Cancer 2002, 35, 242-255.
33. Mollenhauer, J.; Helmke, B.; Muller, H.; Kollender, G.; Lyer, S.; Diedrichs, L.; Holmskov, U.; Ligtenberg, T.; Herbertz, S.; Krebs, I.; Wiemann, S.; Madsen, J.; Bikker, F.; Schmitt, L.; Otto, H.F.; Poustka, A. Sequential changes of the DMBT1 expression and location in normal lung tissue and lung carcinomas. Genes Chromosomes Cancer 2002, 35, 164-169.
34. Mollenhauer, J.; Deichmann, M.; Helmke, B.; Muller, H.; Kollender, G.; Holmskov, U.; Ligtenberg, T.; Krebs, I.; Wiemann, S.; Bantel-Schaal, U.; Madsen, J.; Bikker, F.; Klauck, S.M.; Otto, H.F.; Moldenhauer, G.; Poustka, A. Frequent downregulation of DMBT1 and galectin-3 in epithelial skin cancer. Int. J. Cancer 2003, 105, 149-157.
35. Mollenhauer, J.; Herbertz, S.; Helmke, B.; Kollender, G.; Krebs, I.; Madsen, J.; Holmskov, U.; Sorger, K.; Schmitt, L.; Wiemann, S.; Otto, H.F.; Grone, H.J.; Poustka, A. Deleted in Malignant Brain Tumors 1 is a versatile mucin-like molecule likely to play a differential role in digestive tract cancer. Cancer Res. 2001, 61, 8880-8886.
36. Mollenhauer, J.; Helmke, B.; Medina, D.; Bergmann, G.; Gassler, N.; Muller, H.; Lyer, S.; Diedrichs, L.; Renner, M.; Wittig, R.; Blaich, S.; Hamann, U.; Madsen, J.; Holmskov, U.; Bikker, F.; Ligtenberg, A.; Carlen, A.; Olsson, J.; Otto, H.F.; O'Malley, B.; Poustka, A. Carcinogen inducibility in vivo and down-regulation of DMBTI during breast carcinogenesis. Genes Chromosomes Cancer 2004, 39, 185-194.
37. Aruffo, A.; Bowen, M.A.; Patel, D.D.; Haynes, B.F.; Starling, G.C.; Gebe, J.A.; Bajorath, J. CD6-ligand interactions: A paradigm for SRCR domain function? Immunol. Today 1997, 18, 498-504.
38. Resnick, D.; Pearson, A.; Krieger, M. The SRCR superfamily: A family reminiscent of the Ig superfamily. Trends Biochem. Sci. 1994, 19, 5-8.
39. Bork, P.; Beckmann, G. The CUB Domain - a widespread module in developmentally-regulated proteins. J. Mol. Biol. 1993, 231, 539-545.
40. Sarrias, M.R.; Gronlund, J.; Padilla, O.; Madsen, J.; Holmskov, U.; Lozano, F. The scavenger receptor cysteine-rich (SRCR) domain: An ancient and highly conserved protein module of the innate immune system. Crit. Rev. Immunol. 2004, 24, 1-37.
41. Muller, W.E.G. Origin of metazoan adhesion molecules and adhesion receptors as deduced from cDNA analysis in the marine sponge Geodia cydonium: A review. Cell Tissue Res. 2003, 289, 383-395.
42. Hohenester, E.; Sasaki, T.; Timpl, R. Crystal structure of a scavenger receptor cysteine-rich domain sheds light on an ancient superfamily. Nat. Struct. Biol. 1999, 6, 228-232.
43. Claudianos, C.; Dessens, J.T.; Trueman, H.E.; Arai, M.; Mendoza, J.; Butcher, G.A.; Crompton, T.; Sinden, R.E. A malaria scavenger receptor-like protein essential for parasite development. Mol. Microbiol. 2002, 45, 1473-1484.
44. Abrahamsen, M.S.; Templeton, T.J.; Enomoto, S.; Abrahante, J.E.; Zhu, G.; Lancto, C.A.; Deng, M.Q.; Liu, C.; Widmer, G.; Tzipori, S.; Buck, G.A.; Xu, P.; Bankier, A.T.; Dear, P.H.; Konfortov, B.A.; Spriggs, H.F.; Iyer, L.; Anantharaman, V.; Aravind, L.; Kapur, V. Complete genome sequence of the apicomplexan, Cryptosporidium parvum. Science 2004, 304, 441-445
45. Rast, J.P.; Smith, L.C.; Loza-Coll, M.; Hibino, T.; Litman, G.W. Genomic insights into the immune system of the sea urchin. Science 2006, 314, 952-956.
46. Romero, A.; Romao, M.J.; Varela, P.F.; Kolln, I.; Dias, J.; Carvalho, A.L.; Sanz, L.; Topfer-Petersen, E.; Calvette, J.J. The crystal structures of two spermadhesins reveal the CUB domain fold. Nat. Struct. Biol. 1997, 4, 783-788.
47. Bork, P.; Sander, C. A large domain common to sperm receptors (ZP2 and ZP3) and TGF-beta type-III receptor. Febs Lett. 1992, 300, 237-240.
48. Jovine, L.; Qi, H.Y.; Williams, Z.; Litscher, E.S.; Wassarman, P.M. A duplicated motif controls assembly of zona pellucida domain proteins. Proc. Natl. Acad. Sci. USA 2004, 101, 5922-5927.
49. Jovine, L.; Qi, H.Y.; Williams, Z.; Litscher, E.; Wassarman, P.M. The ZP domain is a conserved module for polymerization of extracellular proteins. Nat. Cell Biol. 2002, 4, 457-461.
50. Jovine, L.; Darie, C.C.; Litscher, E.S.; Wassarman, P.M. Zona pellucida domain proteins. Annu. Rev. Biochem. 2005, 74, 83-114.
51. Young, A.; Rykke, M.; Smistad, G.; Rolla, G. On the role of human salivary micelle-like globules in bacterial agglutination. Eur. J. Oral Sci. 1997, 105, 485-494.
52. Oho, T.; Yu, H.; Yamashita, Y.; Koga, T. Binding of salivary glycoprotein-secretory immunoglobulin a complex to the surface protein antigen of Streptococcus mutans. Infect. Immun. 1998, 66, 115-121.
53. Rose, M.C.; Voter, W.A.; Sage, H.; Brown, C.F.; Kaufman, B. Effects of deglycosylation on the architecture of ovine submaxillary mucin glycoprotein. J. Biol. Chem. 1984, 259, 3167-3172.
54. Amado, M.; Almeida, R.; Schwientek, T.; Clausen, H. Identification and characterization of large galactosyltransferase gene families: Galactosyltransferases for all functions. Biochim. Biophys. Acta-Gen. Subjects 1999, 1473, 35-53.
55. Eriksson, C.; Frangsmyr, L.; Niemi, L.D.; Loimaranta, V.; Holmskov, U.; Bergman, T.; Leffler, H.; Jenkinson, H.F.; Stromberg, N. Variant size- and glycoforms of the scavenger receptor cysteine-rich protein gp-340 with differential bacterial aggregation. Glycoconj. J. 2007, 24, 131-142.
56. Ciopraga, J.; Motas, C.; Doyle, R.J. Inhibition of saliva-induced oral streptococcal aggregation by blood-group glycoproteins. Fems Immun. Med. Microbiol. 1995, 10, 145-149.
57. Ligtenberg, A.J.M.; Veerman, E.C.I.; de Graaff, J.; Nieuw Amerongen, A.V. Influence of the blood-group reactive substances in saliva on the aggregation of Streptococcus rattus. Antonie Van Leeuwenhoek 1990, 57, 97-107.
58. Ligtenberg, A.J.M.; Veerman, E.C.I.; de Graaff, J.; Nieuw Amerongen, A.V. Saliva-induced aggregation of oral streptococci and the influence of blood-group reactive substances. Arch. Oral Biol. 1990, 35, S141-S143.
59. Arneberg, P.; Kornstad, L.; Nordbo, H.; Gjermo, P. Less dental-caries among secretors than among non-secretors of blood-group substance. Scand. J. Dent. Res. 1976, 84, 362-366.
60. Hartshorn, K.L.; Ligtenberg, A.; White, M.R.; van Eijk, M.; Hartshorn, M.; Pemberton, L.; Holmskov, U.; Crouch, E. Salivary agglutinin and lung scavenger receptor cysteine-rich glycoprotein 340 have broad anti-influenza activities and interactions with surfactant protein D that vary according to donor source and sialylation. Biochem. J. 2006, 393, 545-553.
61. Schulz, B.L.; Oxley, D.; Packer, N.H.; Karlsson, N.G. Identification of two highly sialylated human tear-fluid DMBT1 isoforms: The major high-molecular-mass glycoproteins in human tears. Biochem. J. 2002, 366, 511-520.
62. Yeh, J.C.; Hiraoka, N.; Petryniak, B.; Nakayama, J.; Ellies, L.G.; Rabuka, D.; Hindsgaul, O.; Marth, J.D.; Lowe, J.B.; Fukuda, M. Novel sulfated lymphocyte homing receptors and their control by a core1 extension beta1,3-N-acetylglucosaminyltransferase. Cell 2001, 105, 957-969.
63. Prakobphol, A.; Boren, T.; Ma, W.; Peng, Z.X.; Fisher, S.J. Highly glycosylated human salivary molecules present oligosaccharides that mediate adhesion of leukocytes and Helicobacter pylori. Biochemistry 2005, 44, 2216-2224.
64. Issa, S.; Moran, A.P.; Ustinov, S.N.; Lin, J.H.; Ligtenberg, A.J.; Karlsson, N.G. O-linked oligosaccharides from salivary agglutinin: Helicobacter pylori binding sialyl-Lewis x and Lewis b are terminating moieties on hyperfucosylated oligo-N-acetyllactosamine. Glycobiology 2010, 20, 1046-1057.
65. Bikker, F.J.; Ligtenberg, A.J.; Nazmi, K.; Veerman, E.C.; van't Hof, W.; Bolscher, J.G.; Poustka, A.; Nieuw Amerongen, A.V.; Mollenhauer, J. Identification of the bacteria-binding peptide domain on salivary agglutinin (gp-340/DMBT1), a member of the scavenger receptor cysteinerich superfamily. J. Biol. Chem. 2002, 277, 32109-32115.
66. Bikker, F.J.; Ligtenberg, A.J.M.; End, C.; Renner, M.; Blaich, S.; Lyer, S.; Wittig, R.; van't Hof, W.; Veerman, E.C.I.; Nazmi, K.; de Blieck-Hogervorst, J.M.A.; Kioschis, P.; Nieuw Amerongen, A.V.; Poustka, A.; Mollenhauer, J. Bacteria binding by DMBT1/SAG/gp-340 is confined to the VEVLXXXXW motif in its scavenger receptor cysteine-rich domains. J. Biol. Chem. 2004, 279, 47699-47703.
67. Leito, J.T.D.; Ligtenberg, A.J.M.; Nazmi, K.; de Blieck-Hogervorst, J.M.A.; Veerman, E.C.I.; Nieuw Amerongen, A.V. A common binding motif for various bacteria of the bacteria-binding peptide SRCRP2 of DMBT1/gp-340/salivary agglutinin. Biol. Chem. 2008, 389, 1193-1200.
68. Elomaa, O.; Kangas, M.; Sahlberg, C.; Tuukkanen, J.; Sormunen, R.; Liakka, A.; Thesleff, I.; Kraal, G.; Tryggvason, K. Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages. Cell 1995, 80, 603-609.
69. Elomaa, O.; Sankala, M.; Pikkarainen, T.; Bergmann, U.; Tuuttila, A.; Raatikainen-Ahokas, A.; Sariola, H.; Tryggvason, K. Structure of the human macrophage MARCO receptor and characterization of its bacteria-binding region. J. Biol. Chem. 1998, 273, 4530-4538.
70. Kraal, G.; van der Laan, L.J.; Elomaa, O.; Tryggvason, K. The macrophage receptor MARCO. Microb. Infect. 2000, 2, 313-316.
71. Brannstrom, A.; Sankala, M.; Tryggvason, K.; Pikkarainen, T. Arginine residues in domain V have a central role for bacteria-binding activity of macrophage scavenger receptor MARCO. Biochem. Biophys. Res. Commun. 2002, 290, 1462-1469.
72. Sankala, M.; Brannstrom, A.; Schulthess, T.; Bergmann, U.; Morgunova, E.; Engel, J.; Tryggvason, K.; Pikkarainen, T. Characterization of recombinant soluble macrophage scavenger receptor MARCO. J. Biol. Chem. 2002, 277, 33378-33385.
73. Sarrias, M.R.; Rosello, S.; Sanchez-Barbero, F.; Sierra, J.M.; Vila, J.; Yelamos, J.; Vives, J.; Casals, C.; Lozano, F. A role for human SP alpha as a pattern recognition receptor. J. Biol. Chem. 2005, 280, 35391-35398.
74. Sarrias, M.R.; Farnos, M.; Mota, R.; Sanchez-Barbero, F.; Ibanez, A.; Gimferrer, I.; Vera, J.; Fenutria, R.; Casals, C.; Yelamos, J.; Lozano, F. CD6 binds to pathogen-associated molecular patterns and protects from LPS-induced septic shock. Proc. Natl. Acad. Sci. USA 2007, 104, 11724-11729.
75. Fabriek, B.O.; van, B.R.; Deng, D.M.; Ligtenberg, A.J.; Nazmi, K.; Schornagel, K.; Vloet, R.P.; Dijkstra, C.D.; van den Berg, T.K. The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. Blood 2009, 113, 887-892.
76. Schengrund, C.L. Multivalent saccharides: Development of new approaches for inhibiting the effects of glycosphingolipid-binding pathogens. Biochem. Pharmacol. 2003, 65, 699-707.
77. Boren, T.; Falk, P. Helicobacter pylori binds to blood group antigens. Scientific Am. 1994, 28-37.
78. Demuth, D.R.; Lammey, M.S.; Huck, M.; Lally, E.T.; Malamud, D. Comparison of Streptococcus mutans and Streptococcus sanguis receptors for human salivary agglutinin. Microb. Pathogenesis 1990, 9, 199-211.
79. Stenudd, C.; Nordlund, A.; Ryberg, M.; Johansson, I.; Kallestal, C.; Stromberg, N. The association of bacterial adhesion with dental caries. J. Dent. Res. 2001, 80, 2005-2010.
80. Carlen, A.; Bratt, P.; Stenudd, C.; Olsson, J.; Stromberg, N. Agglutinin and acidic proline-rich protein receptor patterns may modulate bacterial adherence and colonization on tooth surfaces. J. Dent. Res. 1998, 77, 81-90.
81. Rosan, B.; Appelbaum, B.; Golub, E.; Malamud, D.; Mandel, I.D. Enhanced saliva-mediated bacterial aggregation and decreased bacterial adhesion in caries-resistant versus cariessusceptible individuals. Infect. Immun. 1982, 38, 1056-1059.
82. Jenkinson, H.F.; Demuth, D.R. Structure, function and immunogenicity of streptococcal antigen I/II polypeptides [review]. Mol. Microbiol. 1997, 23, 183-190.
83. brady, L.J.; Maddocks, S.E.; Larson, M.R.; Forsgren, N.; Persson, K.; Deivanayagam, C.C.; Jenkinson, H.F. The changing faces of Streptococcus antigen I/II polypeptide family adhesins. Mol. Microbiol. 2010, 77, 276-286.
84. Kelly, C.G.; Todryk, S.; Kendal, H.L.; Munro, G.H.; Lehner, T. T-cell, adhesion, and B-cell epitopes of the cell surface Streptococcus mutans protein antigen I/II. Infect. Immun. 1995, 63, 3649-3658.
85. Kelly, C.G.; Younson, J.S.; Hikmat, B.Y.; Todryk, S.M.; Czisch, M.; Haris, P.I.; Flindall, I.R.; Newby, C.; Mallet, A.I.; Ma, J.K.; Lehner, T. A synthetic peptide adhesion epitope as a novel antimicrobial agent. Nat. Biotechnol. 1999, 17, 42-47.
86. Jakubovics, N.S.; Stromberg, N.; van Dolleweerd, C.J.; Kelly, C.G.; Jenkinson, H.F. Differential binding specificities of oral streptococcal antigen I/II family adhesins for human or bacterial ligands. Mol. Microbiol. 2005, 55, 1591-1605.
87. Hamada, T.; Kawashima, M.; Watanabe, H.; Tagami, J.; Senpuku, H. Molecular interactions of surface protein peptides of Streptococcus gordonii with human salivary components. Infect. Immun. 2004, 72, 4819-4826.
88. Koba, H.; Okuda, K.; Watanabe, H.; Tagami, J.; Senpuku, H. Role of lysine in interaction between surface protein peptides of Streptococcus gordonii and agglutinin peptide. Oral Microbiol. Immunol. 2009, 24, 162-169.
89. Oho, T.; Bikker, F.J.; Nieuw Amerongen, A.V.; Groenink, J. A peptide domain of bovine milk lactoferrin inhibits the interaction between streptococcal surface protein antigen and a salivary agglutinin peptide domain. Infect. Immun. 2004, 72, 6181-6184.
90. Niemi, L.D.; Johansson, I. Salivary statherin peptide-binding epitopes of commensal and potentially infectious Actinomyces spp. delineated by a hybrid peptide construct. Infect. Immun. 2004, 72, 782-787.
91. Niemi, L.D.; Hernell, O.; Johansson, I. Human milk compounds inhibiting adhesion of mutans streptococci to host ligand-coated hydroxyapatite in vitro. Caries Res. 2009, 43, 171-178.
92. Wu, Z.W.; Golub, E.; Abrams, W.R.; Malamud, D. gp340 (SAG) binds to the V3 sequence of gp120 important for chemokine receptor interaction. Aids Res. Hum. Retroviruses 2004, 20, 600-607.
93. Larson, M.R.; Rajashankar, K.R.; Patel, M.H.; Robinette, R.A.; Crowley, P.J.; Michalek, S.; Brady, L.J.; Deivanayagam, C. Elongated fibrillar structure of a streptococcal adhesin assembled by the high-affinity association of alpha- and PPII-helices. Proc. Natl. Acad. Sci. USA 2010, 107, 5983-5988.
94. Troffer-Charlier, N.; Ogier, J.; Moras, D.; Cavarelli, J. Crystal structure of the V-region of Streptococcus mutans antigen I/II at 2.4 angstrom resolution suggests a sugar preformed binding site. J. Mol. Biol. 2002, 318, 179-188.
95. Loimaranta, V.; Jakubovics, N.S.; Hytonen, J.; Finne, J.; Jenkinson, H.F.; Stromberg, N. Fluid-or surface-phase human salivary scavenger protein gp340 exposes different bacterial recognition properties. Infect. Immun. 2005, 73, 2245-2252.
96. Brady, L.J.; Piacentini, D.A.; Crowley, P.J.; Oyston, P.C.F.; Bleiweis, A.S. Differentiation of salivary agglutinin-mediated adherence and aggregation of mutans streptococci by use of monoclonal-antibodies against the major surface adhesin-P1. Infect. Immun. 1992, 60, 1008-1017.
97. Zhang, Y.; Lei, Y.; Nobbs, A.; Khammanivong, A.; Herzberg, M.C. Inactivation of Streptococcus gordonii SspAB alters expression of multiple adhesin genes. Infect. Immun. 2005, 73, 3351-3357.
98. Gibbons, R.J.; Hay, D.I.; Childs, W.C.; Davis, G. Role of cryptic receptors (cryptitopes) in bacterial adhesion to oral-surfaces. Arch. Oral Biol. 1990, 35, S107-S114.
99. Gibbons, R.J.; Hay, D.I. Human salivary acidic proline-rich proteins and statherin promote the attachment of Actinomyces viscosus LY7 to apatitic surfaces. Infect. Immun. 1988, 56, 439-445.
100. Goobes, G.; Goobes, R.; Schueler-Furman, O.; Baker, D.; Stayton, P.S.; Drobny, G.P. Folding of the C-terminal bacterial binding domain in statherin upon adsorption onto hydroxyapatite crystals. Proc. Natl. Acad. Sci. USA 2006, 103, 16083-16088.
101. Madsen, J.; Tornoe, I.; Nielsen, O.; Lausen, M.; Krebs, I.; Mollenhauer, J.; Kollender, G.; Poustka, A.; Skjodt, K.; Holmskov, U. CRP-ductin, the mouse homologue of gp-340/deleted in malignant brain tumors 1 (DMBT1), binds gram-positive and gram-negative bacteria and interacts with lung surfactant protein D. Eur. J. Immunol. 2003, 33, 2327-2336
102. End, C.; Bikker, F.; Renner, M.; Bergmann, G.; Lyer, S.; Blaich, S.; Hudler, M.; Helmke, B.; Gassler, N.; Autschbach, F.; Ligtenberg, A.J.; Benner, A.; Holmskov, U.; Schirmacher, P.; Nieuw Amerongen, A.V.; Rosenstiel, P.; Sina, C.; Franke, A.; Hafner, M.; Kioschis, P.; Schreiber, S.; Poustka, A.; Mollenhauer, J. DMBT1 functions as pattern-recognition molecule for poly-sulfated and poly-phosphorylated ligands. Eur. J. Immunol. 2009, 39, 833-842.
103. Wu, Z.; Van Ryk, D.; Davis, C.; Abrams, W.R.; Chaiken, I.; Magnani, J.; Malamud, D. Salivary agglutinin inhibits HIV type 1 infectivity through interaction with viral glycoprotein 120. Aids Res. Hum. Retroviruses 2003, 19, 201-209.
104. Hartshorn, K.L.; White, M.R.; Mogues, T.; Ligtenberg, T.; Crouch, E.; Holmskov, U. Lung and salivary scavenger receptor glycoprotein-340 contribute to the host defense against influenza A viruses. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2003, 285, L1066-L1076.
105. Sattentau, Q.J.; Moore, J.P. Conformational changes induced in the human-immunodeficiency- virus envelope glycoprotein by soluble CD4 binding. J. Exp. Med. 1991, 174, 407-415.
106. Trkola, A.; Dragic, T.; Arthos, J.; Binley, J.M.; Olson, W.C.; Allaway, G.P.; ChengMayer, C.; Robinson, J.; Maddon, P.J.; Moore, J.P. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 1996, 384, 184-187.
107. Wu, Z.W.; Lee, S.; Abrams, W.; Weissman, D.; Malamud, D. The N-terminal SRCR-SID domain of gp-340 interacts with HIV type 1 gp120 sequences and inhibits viral infection. Aids Res. Hum. Retroviruses 2006, 22, 508-515.
108. Thornton, D.J.; Davies, J.R.; Kirkham, S.; Gautrey, A.; Khan, N.; Richardson, P.S.; Sheehan, J.K. Identification of a nonmucin glycoprotein (gp-340) from a purified respiratory mucin preparation: Evidence for an association involving the MUC5B mucin. Glycobiology 2001, 11, 969-977.
109. Kojouharova, M.S.; Tsacheva, I.G.; Tchorbadjieva, M.I.; Reid, K.B.M.; Kishore, U. Localization of ligand-binding sites on human C1q globular head region using recombinant globular head fragments and single-chain antibodies. Biochim. Biophys. Acta-Proteins Proteomics 2003, 1652, 64-74.
110. Armstrong, E.A.; Ziola, B.; Habbick, B.F.; Komiyama, K. Role of cations and IgA in saliva- mediated aggregation of Pseudomonas aeruginosa in cystic-fibrosis patients. J. Oral Pathol. Med. 1993, 22, 207-213.
111. Singh, P.K.; Parsek, M.R.; Greenberg, E.P.; Welsh, M.J. A component of innate immunity prevents bacterial biofilm development. Nature 2002, 417, 552-555.
112. Groenink, J.; Walgreen-Weterings, E.; van 't Hof, W.; Veerman, E.C.I.; Nieuw Amerongen, A.V. Cationic amphipatic peptides, derived from bovine and human lactoferrins, with antimicrobial activity against oral pathogens. FEMS Microbiol. Lett. 1999, 179, 217-222.
113. Kishore, U.; Greenhough, T.J.; Waters, P.; Shrive, A.K.; Ghai, R.; Kamran, M.F.; Bernal, A.L.; Reid, K.B.M.; Madan, T.; Chakraborty, T. Surfactant proteins SP-A and SP-D: Structure, function and receptors. Mol. Immunol. 2006, 43, 1293-1315.
114. Hoffmann, J.A.; Kafatos, F.C.; Janeway, C.A.; Ezekowitz, R.A. Phylogenetic perspectives in innate immunity. Science 1999, 1313-1318.
115. Janeway, C., Jr.; Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 2003, 20, 197-216.
116. Bainbridge, B.W.; Darveau, R.P. Porphyromonas gingivalis lipopolysaccharide: An unusual pattern recognition receptor ligand for the innate host defense system. Acta Odontol. Scand. 2001, 59, 131-138.
117. Ulevitch, R.J.; Mathison, J.C.; Correia, J.D. Innate immune responses during infection. Vaccine 2004, 22, S25-S30.
118. Medzhitov, R.; Janeway, C., Jr. Innate immunity. N. Engl. J. Med. 2000, 343, 338-343.
119. Aderem, A.; Ulevitch, R.J. Toll-like receptors in the induction of the innate immune response. Nature 2000, 406, 782-787.
120. Greaves, D.R.; Gordon, S. Recent insights into the biology of macrophage scavenger receptors. J. Lipid Res. 2005, 46, 11-20.